Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
01.26.23
OpGen subsidiary Ares Genetics announces granting of key patent in China
01.18.23
OpGen Provides Preliminary Unaudited Revenue for FY 2022 and Business Update
01.17.23
OpGen Subsidiary Curetis Meets Several Key Milestones in FIND Collaboration Project

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events